Table 2. Trends in BP and cholesterol measurements between 2008 and 2018.
| Annual measurements (2008–2018) | ||
|---|---|---|
| BP | Cholesterol | |
| CVD and DM (%) | 68.5–78.7 (P<0.001) | 57.9–69.6 (P<0.001) |
| DM only (%) | 61.5–73.3 (P = 0.002) | 56.8–65.8 (P = 0.001) |
| CVD only (%) | 37.0–48.4 (P<0.001) | 25.8–40.2 (P<0.001) |
| Indication for CRA (%) | 33.0–31.9 (P = 0.37) | 25.7–27.7 (P = 0.43) |
| No indication for CRA (%) | 4.7–6.2 (P = 0.034) | 4.3–3.9 (P = 0.53) |
| Measurements every 2 years (2009–2010 and 2017–2018) | ||
| BP | Cholesterol | |
| CVD and DM (%) | 80.8–87.6 (P<0.001) | 75.9–82.7 (P<0.001) |
| DM only (%) | 76.2–82.2 (P = 0.006) | 73.2–79.3 (P<0.001) |
| CVD only (%) | 54.5–64.2 (P<0.001) | 45.7–56.8 (P<0.001) |
| Indication for CRA (%) | 47.0–45.8 (P = 0.99) | 41.7–41.1 (P = 0.85) |
| No indication for CRA (%) | 9.2–11.1 (P = 0.36) | 8.0–7.4 (P = 0.12) |
| Measurements every 5 years (2009–2013 and 2014–2018) | ||
| BP | Cholesterol | |
| CVD and DM (%) | 93.2–93.7 (P = 0.073) | 88.1–89.1 (P = 0.082) |
| DM only (%) | 88.5–88.9 (P = 0.65) | 84.8–85.8 (P = 0.057) |
| CVD only (%) | 78.6–81.2 (P<0.001) | 70.6–74.2 (P = 0.002) |
| Indication for CRA (%) | 68.5–66.2 (P = 0.023) | 62.7–60.5 (P = 0.009) |
| No indication for CRA (%) | 19.6–22.4 (P = 0.10) | 16.3–16.0 (P = 0.12) |
Patients were classified as ‘Indication for CRA’ if they did not have a history of CVD or DM, but did have a history of one of the following: rheumatoid arthritis, pre-eclampsia, pregnancy-induced DM, family history of CVD, obesity, smoking, hypertension, dyslipidaemia, chronic kidney disease, use of antihypertensive or lipid-lowering medication.
BP = blood pressure. CRA = cardiovascular risk assessment. CVD = cardiovascular disease.